Logo image of CVE-PR-A.CA

CENOVUS ENERGY INC - CVECN 2.404 PERP (CVE-PR-A.CA) Stock Fundamental Analysis

TSX:CVE-PR-A - Toronto Stock Exchange - CA15135U3073 - Currency: CAD

23.73  +0.1 (+0.42%)

Fundamental Rating

5

CVE-PR-A gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 208 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and the financial health of CVE-PR-A get a neutral evaluation. Nothing too spectacular is happening here. CVE-PR-A has a decent growth rate and is not valued too expensively. CVE-PR-A also has an excellent dividend rating. These ratings would make CVE-PR-A suitable for dividend investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CVE-PR-A had positive earnings in the past year.
CVE-PR-A had a positive operating cash flow in the past year.
Of the past 5 years CVE-PR-A 4 years were profitable.
CVE-PR-A had a positive operating cash flow in each of the past 5 years.
CVE-PR-A.CA Yearly Net Income VS EBIT VS OCF VS FCFCVE-PR-A.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

CVE-PR-A's Return On Assets of 4.95% is fine compared to the rest of the industry. CVE-PR-A outperforms 76.33% of its industry peers.
CVE-PR-A has a better Return On Equity (9.30%) than 72.46% of its industry peers.
The Return On Invested Capital of CVE-PR-A (7.38%) is better than 76.33% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CVE-PR-A is above the industry average of 7.37%.
The last Return On Invested Capital (7.38%) for CVE-PR-A is well below the 3 year average (11.92%), which needs to be investigated, but indicates that CVE-PR-A had better years and this may not be a problem.
Industry RankSector Rank
ROA 4.95%
ROE 9.3%
ROIC 7.38%
ROA(3y)8.18%
ROA(5y)3.66%
ROE(3y)15.96%
ROE(5y)7.2%
ROIC(3y)11.92%
ROIC(5y)N/A
CVE-PR-A.CA Yearly ROA, ROE, ROICCVE-PR-A.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

With a Profit Margin value of 5.15%, CVE-PR-A perfoms like the industry average, outperforming 56.52% of the companies in the same industry.
CVE-PR-A's Profit Margin has declined in the last couple of years.
CVE-PR-A has a Operating Margin (8.54%) which is in line with its industry peers.
In the last couple of years the Operating Margin of CVE-PR-A has grown nicely.
Looking at the Gross Margin, with a value of 32.07%, CVE-PR-A is in line with its industry, outperforming 48.79% of the companies in the same industry.
CVE-PR-A's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.54%
PM (TTM) 5.15%
GM 32.07%
OM growth 3Y-3.42%
OM growth 5Y2.33%
PM growth 3Y68.65%
PM growth 5Y-12.05%
GM growth 3Y-13%
GM growth 5Y-11.02%
CVE-PR-A.CA Yearly Profit, Operating, Gross MarginsCVE-PR-A.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

5

2. Health

2.1 Basic Checks

CVE-PR-A has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CVE-PR-A has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CVE-PR-A has been increased compared to 5 years ago.
Compared to 1 year ago, CVE-PR-A has a worse debt to assets ratio.
CVE-PR-A.CA Yearly Shares OutstandingCVE-PR-A.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CVE-PR-A.CA Yearly Total Debt VS Total AssetsCVE-PR-A.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

CVE-PR-A has an Altman-Z score of 2.55. This is not the best score and indicates that CVE-PR-A is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.55, CVE-PR-A is in the better half of the industry, outperforming 76.33% of the companies in the same industry.
The Debt to FCF ratio of CVE-PR-A is 3.53, which is a good value as it means it would take CVE-PR-A, 3.53 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.53, CVE-PR-A belongs to the top of the industry, outperforming 81.16% of the companies in the same industry.
CVE-PR-A has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
CVE-PR-A's Debt to Equity ratio of 0.34 is in line compared to the rest of the industry. CVE-PR-A outperforms 52.66% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 3.53
Altman-Z 2.55
ROIC/WACC0.83
WACC8.89%
CVE-PR-A.CA Yearly LT Debt VS Equity VS FCFCVE-PR-A.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

CVE-PR-A has a Current Ratio of 1.46. This is a normal value and indicates that CVE-PR-A is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.46, CVE-PR-A is doing good in the industry, outperforming 69.57% of the companies in the same industry.
CVE-PR-A has a Quick Ratio of 1.46. This is a bad value and indicates that CVE-PR-A is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.84, CVE-PR-A perfoms like the industry average, outperforming 59.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.46
Quick Ratio 0.84
CVE-PR-A.CA Yearly Current Assets VS Current LiabilitesCVE-PR-A.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

5

3. Growth

3.1 Past

CVE-PR-A shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -39.49%.
Measured over the past years, CVE-PR-A shows a very strong growth in Earnings Per Share. The EPS has been growing by 33.97% on average per year.
Looking at the last year, CVE-PR-A shows a small growth in Revenue. The Revenue has grown by 1.57% in the last year.
Measured over the past years, CVE-PR-A shows a very strong growth in Revenue. The Revenue has been growing by 21.88% on average per year.
EPS 1Y (TTM)-39.49%
EPS 3Y87.2%
EPS 5Y33.97%
EPS Q2Q%-28.34%
Revenue 1Y (TTM)1.57%
Revenue growth 3Y5.4%
Revenue growth 5Y21.88%
Sales Q2Q%-3.99%

3.2 Future

Based on estimates for the next years, CVE-PR-A will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.52% on average per year.
CVE-PR-A is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.74% yearly.
EPS Next Y6.62%
EPS Next 2Y18.58%
EPS Next 3Y19.52%
EPS Next 5YN/A
Revenue Next Year-8.98%
Revenue Next 2Y-4.96%
Revenue Next 3Y-5.74%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CVE-PR-A.CA Yearly Revenue VS EstimatesCVE-PR-A.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B
CVE-PR-A.CA Yearly EPS VS EstimatesCVE-PR-A.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 -2 3

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.25 indicates a correct valuation of CVE-PR-A.
Based on the Price/Earnings ratio, CVE-PR-A is valued a bit cheaper than 60.87% of the companies in the same industry.
When comparing the Price/Earnings ratio of CVE-PR-A to the average of the S&P500 Index (25.82), we can say CVE-PR-A is valued slightly cheaper.
With a Price/Forward Earnings ratio of 10.29, the valuation of CVE-PR-A can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CVE-PR-A is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of CVE-PR-A to the average of the S&P500 Index (21.76), we can say CVE-PR-A is valued rather cheaply.
Industry RankSector Rank
PE 16.25
Fwd PE 10.29
CVE-PR-A.CA Price Earnings VS Forward Price EarningsCVE-PR-A.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CVE-PR-A indicates a somewhat cheap valuation: CVE-PR-A is cheaper than 78.26% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CVE-PR-A is valued a bit cheaper than the industry average as 66.18% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.17
EV/EBITDA 5.28
CVE-PR-A.CA Per share dataCVE-PR-A.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CVE-PR-A has a very decent profitability rating, which may justify a higher PE ratio.
CVE-PR-A's earnings are expected to grow with 19.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.46
PEG (5Y)0.48
EPS Next 2Y18.58%
EPS Next 3Y19.52%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.35%, CVE-PR-A is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.53, CVE-PR-A pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.39, CVE-PR-A pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.35%

5.2 History

The dividend of CVE-PR-A is nicely growing with an annual growth rate of 31.72%!
CVE-PR-A has been paying a dividend for at least 10 years, so it has a reliable track record.
CVE-PR-A has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)31.72%
Div Incr Years0
Div Non Decr Years7
CVE-PR-A.CA Yearly Dividends per shareCVE-PR-A.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

57.77% of the earnings are spent on dividend by CVE-PR-A. This is a bit on the high side, but may be sustainable.
The dividend of CVE-PR-A is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP57.77%
EPS Next 2Y18.58%
EPS Next 3Y19.52%
CVE-PR-A.CA Yearly Income VS Free CF VS DividendCVE-PR-A.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B
CVE-PR-A.CA Dividend Payout.CVE-PR-A.CA Dividend Payout, showing the Payout Ratio.CVE-PR-A.CA Dividend Payout.PayoutRetained Earnings

CENOVUS ENERGY INC - CVECN 2.404 PERP

TSX:CVE-PR-A (5/23/2025, 7:00:00 PM)

23.73

+0.1 (+0.42%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners50.86%
Inst Owner ChangeN/A
Ins Owners0.81%
Ins Owner ChangeN/A
Market Cap43.25B
Analysts81.82
Price Target36.82 (55.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.35%
Yearly Dividend0.84
Dividend Growth(5Y)31.72%
DP57.77%
Div Incr Years0
Div Non Decr Years7
Ex-Date06-13 2025-06-13 (0.16106)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-27.08%
Min EPS beat(2)-72.97%
Max EPS beat(2)18.8%
EPS beat(4)1
Avg EPS beat(4)-20.32%
Min EPS beat(4)-72.97%
Max EPS beat(4)18.8%
EPS beat(8)4
Avg EPS beat(8)-7.43%
EPS beat(12)6
Avg EPS beat(12)-11.06%
EPS beat(16)7
Avg EPS beat(16)-22.03%
Revenue beat(2)0
Avg Revenue beat(2)-9.48%
Min Revenue beat(2)-10.43%
Max Revenue beat(2)-8.54%
Revenue beat(4)2
Avg Revenue beat(4)-1.48%
Min Revenue beat(4)-10.43%
Max Revenue beat(4)9.24%
Revenue beat(8)4
Avg Revenue beat(8)-0.48%
Revenue beat(12)7
Avg Revenue beat(12)5.51%
Revenue beat(16)11
Avg Revenue beat(16)5.81%
PT rev (1m)5.82%
PT rev (3m)12.64%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.2%
EPS NY rev (1m)0%
EPS NY rev (3m)-16.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.4%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)-2.83%
Valuation
Industry RankSector Rank
PE 16.25
Fwd PE 10.29
P/S 0.8
P/FCF 14.17
P/OCF 5.24
P/B 1.44
P/tB 1.6
EV/EBITDA 5.28
EPS(TTM)1.46
EY6.15%
EPS(NY)2.31
Fwd EY9.72%
FCF(TTM)1.68
FCFY7.06%
OCF(TTM)4.53
OCFY19.1%
SpS29.73
BVpS16.48
TBVpS14.87
PEG (NY)2.46
PEG (5Y)0.48
Profitability
Industry RankSector Rank
ROA 4.95%
ROE 9.3%
ROCE 9.36%
ROIC 7.38%
ROICexc 7.81%
ROICexgc 8.33%
OM 8.54%
PM (TTM) 5.15%
GM 32.07%
FCFM 5.64%
ROA(3y)8.18%
ROA(5y)3.66%
ROE(3y)15.96%
ROE(5y)7.2%
ROIC(3y)11.92%
ROIC(5y)N/A
ROICexc(3y)12.89%
ROICexc(5y)N/A
ROICexgc(3y)13.8%
ROICexgc(5y)N/A
ROCE(3y)15.07%
ROCE(5y)N/A
ROICexcg growth 3Y-0.51%
ROICexcg growth 5Y16.37%
ROICexc growth 3Y0.11%
ROICexc growth 5Y16.58%
OM growth 3Y-3.42%
OM growth 5Y2.33%
PM growth 3Y68.65%
PM growth 5Y-12.05%
GM growth 3Y-13%
GM growth 5Y-11.02%
F-Score4
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 3.53
Debt/EBITDA 1.06
Cap/Depr 104.37%
Cap/Sales 9.61%
Interest Coverage 250
Cash Conversion 85.89%
Profit Quality 109.35%
Current Ratio 1.46
Quick Ratio 0.84
Altman-Z 2.55
F-Score4
WACC8.89%
ROIC/WACC0.83
Cap/Depr(3y)91.58%
Cap/Depr(5y)68.62%
Cap/Sales(3y)7.67%
Cap/Sales(5y)7.01%
Profit Quality(3y)110.56%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.49%
EPS 3Y87.2%
EPS 5Y33.97%
EPS Q2Q%-28.34%
EPS Next Y6.62%
EPS Next 2Y18.58%
EPS Next 3Y19.52%
EPS Next 5YN/A
Revenue 1Y (TTM)1.57%
Revenue growth 3Y5.4%
Revenue growth 5Y21.88%
Sales Q2Q%-3.99%
Revenue Next Year-8.98%
Revenue Next 2Y-4.96%
Revenue Next 3Y-5.74%
Revenue Next 5YN/A
EBIT growth 1Y-29.74%
EBIT growth 3Y1.79%
EBIT growth 5Y24.73%
EBIT Next Year119.72%
EBIT Next 3Y27.43%
EBIT Next 5Y17.31%
FCF growth 1Y-46.33%
FCF growth 3Y7.94%
FCF growth 5Y14.96%
OCF growth 1Y-15.29%
OCF growth 3Y15.98%
OCF growth 5Y22.96%